Blog
The regulatory costs we still aren’t counting
Several years ago, I assembled a “Costberg” working paper surveying the largely impenetrable and undisclosed costs of regulation. The project grew out of…
Comment
CEI Comments on 340B Payment Change
The Competitive Enterprise Institute (CEI) submits these comments in support of several of the provisions in the rule recently proposed by CMS. Founded in…
Blog
The week in regulations: Voting by mail and $100,000 visas
The number of new final regulations in 2026 topped the 2,000 mark. President Trump escalated his trade war against Canada and issued an executive…
Reason
Canada Should Ignore Trump’s Protectionism and Unilaterally Enact Free Trade
CEI’s Senior Economist Ryan Young was cited by Reason regarding free trade. “Canadian Prime Minister Carney’s retaliatory tariffs come from understandable feelings…
Blog
Free the Economy podcast: The future of financial regulation with Thomas Hoenig
In this week’s episode we cover the status of occupational licensing in the 50 states, the coming crack-up over entitlement spending,…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…